Press Release

Biopsy Devices Market to witness a CAGR of 7.9% by 2025; Rising Prevalence of Cancer Globally to Drive Market Growth
May 2021

Biopsy Devices Market to witness a CAGR of 7.9% by 2025; Rising Prevalence of Cancer Globally to Drive Market Growth

The global Biopsy Devices Market is valued at USD 2,043.5 million in 2019 and is expected to grow at a CAGR of 7.9% by 2025, according to a new research report by iCognition Insights Pvt. Ltd. This global report on Biopsy Devices focuses on market size and forecast at global, segmental, regional and country level providing an end-to-end market overview of the industry segment for period 2019-2025. The report further delivers key insights on the historical market size, market drivers, restraints, future opportunities, and market dynamics driving the growth by 2025. iCognition Insights have analyzed the competition- key market leaders and new market entrants offering deep-dive intelligence on their strategies and market approaches, mergers and acquisitions, disruptive technologies which could alter or change the entire market trend.

A biopsy is a medical procedure to remove a small sample of tissue from the body for further analysis in a laboratory. This tissue sample can be taken from anywhere on, or in the body, including liver, lungs, breast, stomach and skin. Doctors, surgeons, radiologists and cardiologists generally recommend the procedure to investigate the cause of patient’s symptoms or to diagnose the occurrence or severity of several health conditions like cancer and inflammatory diseases. The equipment used for the surgical extraction of tissues from an organ are referred to as biopsy devices. The practice of a variety of biopsy devices varies with the types of biopsy conducted or organ under consideration. Increasing incidence of cancer, such as breast, lung, blood and bladder have demanded for highly sophisticated and minimally invasive procedures, fueling the growth of global biopsy devices market. According to the Global Cancer Observatory, in 2020, around 19 million new cancer cases were recorded globally, with breast cancer (2.2 million), lung cancer (2.2 million) and colorectal cancer (1.9 million) becoming the most common cancers occurring worldwide. Furthermore, rising awareness amongst the practitioners and consumers regarding availability of screening procedures for chronic conditions is fostering the demand for integrated biopsy technologies such as MR-guided biopsy technology. However, high cost of biopsy devices is the major aspect that deters the market growth.

Request for a detailed market summary, research scope and table of contents @ Biopsy Devices Market: Report Sample

The Biopsy Devices Market is segmented based on Product (Needle-based biopsy guns, Biopsy guidance systems, Biopsy needles, Biopsy forceps, Other biopsy devices) and by Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Global Biopsy Devices Market Share Analysis:

  • In 2019, the needle-based biopsy guns segment held the largest market share due to its increasing demand for tissue collection from organs like lungs and breasts. The vacuum-assisted biopsy devices segment is expected to show an exponential growth during the forecast period to 2025. This is attributed to its advantages such as minimally invasive procedure and high precision.
  • North America accounted for the highest revenue share in 2019 and is projected to maintain its dominance during the forecast period. This is due to the increasing prevalence of chronic diseases like cancer in the North America region, especially the U.S. which is listed amongst the top 5 countries with highest cancer rates.
  • Due to high population base, unmet medical needs and fostering industry-research collaborations, Asia Pacific is projected to exhibit the fastest CAGR over the forecast period.

Key Industry Developments:

  • March 2021:S. headquartered precision oncology company Lucence partnered with Waseda University in Japan to develop a novel high-speed liquid biopsy laser-based imaging platform for early cancer screening.
  • August 2020: Hologic Inc., a U.S. headquartered medical technology company announced technology updates to their Brevera Breast Biopsy System. The improved biopsy system claims to be the world’s first and only breast biopsy system to integrate vacuum-assisted tissue acquisition, real-time imaging verification and advanced post-biopsy handling in one, uniform system.

Key Leading Companies Profiled in the Biopsy Devices Market Analysis Report:

This exhaustive research report analyzes 13 global companies that are adopting innovative technologies and approaches to gain maximum market share.

  • R. Bard, Inc. (U.S.)
  • Cook Group Incorporated (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Leica Biosystems (Germany)
  • Olympus Corporation (Japan)
  • FUJIFILM Holdings Corporation (Japan)
  • Becton, Dickinson and Company (U.S.)
  • Argon Medical Devices (U.S.)
  • INRAD, Inc. (U.S.)
  • Cardinal Health, Inc. (U.S.)
  • Devicor Medical Products, Inc. (US)
  • Braun Melsungen AG (Germany)
  • Medtronic plc (Ireland)

Research Scope and Market Segmentation of Biopsy Devices Report:

Key Parameters Details
Analysis Period 2017-2025
Historical Period 2017-2019
Forecast Period 2020-2025
Segmentation Product, Geography
Based on Product
  • Needle-based biopsy guns
    • Vacuum-assisted biopsy devices
    • Fine needle aspiration biopsy devices
    • Core needle biopsy devices
  • Biopsy guidance systems
    • Manual guidance system
    • Robotic guidance system
  • Biopsy Needles
    • Disposable biopsy needles
    • Reusable biopsy needles
  • Biopsy Forceps
    • Cold/General biopsy forceps
    • Hot biopsy forceps
  • Other Biopsy Devices
    • Brushes
    • Curettes
    • Punches
Based on Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • South Korea
    • India
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Express buy the full report @ Purchase Report: Checkout


Contact Us:

Call Us: +1 617 676 0160 | +81 503 196 4844


Follow Us to stay on top of the industry insights and latest market trends: